NCT07625865

Brief Summary

This randomized controlled trial evaluates the safety and feasibility of drainless thyroid surgery for benign thyroid diseases using a sutureless hemostatic technique. Patients undergoing thyroidectomy are randomized to either drainless surgery or surgery with drain placement. The study compares postoperative outcomes, including complications, pain, hospital stay, and need for reintervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 20, 2023

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 20, 2025

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

January 3, 2026

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 29, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

June 4, 2026

Completed
Last Updated

June 4, 2026

Status Verified

February 1, 2026

Enrollment Period

2.2 years

First QC Date

May 29, 2026

Last Update Submit

May 29, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of postoperative neck hematoma requiring intervention

    Any postoperative cervical hematoma causing airway compromise or requiring surgical re-exploration or invasive evacuation

    Within 48 hours postoperatively

Secondary Outcomes (4)

  • 1. Overall postoperative complication rate

    Within 30 days postoperatively

  • 2. Seroma formation

    Within 14 days postoperatively

  • 3. Postoperative hypocalcemia

    Within 72 hours postoperatively

  • Recurrent laryngeal nerve injury

    Within 30 days postoperatively

Study Arms (2)

thyroidectomy without drain

ACTIVE COMPARATOR

Participants in this arm undergo sutureless thyroidectomy procedure, but no surgical drain is placed afterward. The aim is to evaluate whether omitting the drain affects outcomes such as postoperative surgical site complications (like pain, infection, seroma, hematoma) compared with the drained approach.

Procedure: sutureless thyroidectomy without drain

thyroidectomy with drain

ACTIVE COMPARATOR

Participants in this arm undergo sutureless thyroidectomy for benign thyroid disease with placement of a subcutaneous suction drain at the end of the procedure. The purpose of using the drain is to evacuate any postoperative fluid such as blood or serous fluid from the surgical site to theoretically reduce complications such as hematoma or seroma accumulation.

Procedure: sutureless thyroidectomy with drain

Interventions

Participants undergo sutureless thyroidectomy procedure but no drain is placed postoperatively. The goal is to assess whether omitting the drain affects postoperative outcomes such as pain, seroma, hematoma, infection, or overall recovery, while maintaining safety.

thyroidectomy without drain

Participants undergo sutureless thyroidectomy for benign thyroid disease with placement of a subcutaneous suction drain. The drain is intended to evacuate postoperative fluid (blood or serous fluid) to reduce the risk of complications such as hematoma or seroma formation. The surgical technique itself follows conventional sutureless thyroidectomy principles.

thyroidectomy with drain

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Adult patients (≥18 years)
  • Benign thyroid disease confirmed by: clinical assessment, ultrasonography, and fine-needle aspiration cytology (Bethesda II)
  • Indicated for elective hemithyroidectomy or total thyroidectomy
  • Euthyroid or adequately controlled thyroid function

You may not qualify if:

  • Thyroid malignancy or indeterminate cytology
  • Re-operative thyroid surgery
  • Retrosternal goiter
  • Coagulation disorders
  • Patients on anticoagulation that could not be safely discontinued
  • Concomitant neck surgery
  • Severe uncontrolled systemic illness (ASA IV or higher)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Minia University

Minya, 61111, Egypt

Location

MeSH Terms

Interventions

Drainage

Intervention Hierarchy (Ancestors)

TherapeuticsSurgical Procedures, Operative

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

May 29, 2026

First Posted

June 4, 2026

Study Start

October 20, 2023

Primary Completion

December 20, 2025

Study Completion

January 3, 2026

Last Updated

June 4, 2026

Record last verified: 2026-02

Locations